Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Zoetis
(NY:
ZTS
)
118.65
-1.76 (-1.46%)
Official Closing Price
Updated: 4:10 PM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Zoetis
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
Zoetis Barks Up A Third-Quarter Beat And Raise, But Stock Slips
↗
November 04, 2024
Zoetis stock inched higher Monday after the animal health company beat third-quarter expectations and raised its outlook.
Via
Investor's Business Daily
Zoetis Announces Third Quarter 2024 Results
November 04, 2024
From
Zoetis Inc.
Via
Business Wire
'Venture Investing Is Random,' Says Kevin O'Leary. The Craziest Bets, Like Cat DNA Tests, Often Cover All The Losses
↗
October 31, 2024
Via
Benzinga
Here's How Much $1000 Invested In Zoetis 10 Years Ago Would Be Worth Today
↗
October 14, 2024
Via
Benzinga
In-Depth Examination Of 7 Analyst Recommendations For Zoetis
↗
October 11, 2024
Via
Benzinga
$1000 Invested In Zoetis 10 Years Ago Would Be Worth This Much Today
↗
September 30, 2024
Via
Benzinga
Where Zoetis Stands With Analysts
↗
September 18, 2024
Via
Benzinga
Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years
↗
September 05, 2024
Via
Benzinga
Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today
↗
August 23, 2024
Via
Benzinga
Zoetis Declares Fourth Quarter 2024 Dividend
October 10, 2024
From
Zoetis Inc.
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
↗
October 07, 2024
Via
Benzinga
Zoetis and Danone Announce Strategic Partnership to Pioneer Sustainable Innovation in Dairy Farming Using the Power of Genetics
September 26, 2024
From
Zoetis Inc.
Via
Business Wire
How Is The Market Feeling About Zoetis?
↗
August 16, 2024
Via
Benzinga
The Latest Analyst Ratings For Zoetis
↗
August 14, 2024
Via
Benzinga
Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today
↗
August 12, 2024
Via
Benzinga
Why Zoetis Stock Was Moving Higher Tuesday
↗
August 06, 2024
It was a classic beat-and-raise quarter for Zoetis.
Via
The Motley Fool
Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy
↗
September 20, 2024
FDA approves Elanco's once-daily oral treatment, Zenrelia, for controlling itching in dogs with allergic and atopic dermatitis. The drug, proven effective in studies, faces adoption challenges due to...
Via
Benzinga
Zoetis to Host Webcast and Conference Call on Third Quarter 2024 Financial Results
September 19, 2024
From
Zoetis Inc.
Via
Business Wire
Starbucks To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Wednesday
↗
September 18, 2024
Via
Benzinga
Jim Cramer Says This Retailer Yields 3%: 'Which Is Quite Good'
↗
September 04, 2024
Jim Cramer discusses PROCEPT BioRobotics, Zoetis, Target and Consolidated Edison. "
Via
Benzinga
Zoetis Earnings Growth Picks Up, Tops Views
↗
August 06, 2024
The animal drug giant's EPS growth had decelerated in the prior two quarters.
Via
Investor's Business Daily
NYSE:ZTS Shows Potential for a Breakout.
↗
July 30, 2024
Will ZOETIS INC Break Out? A Technical Analysis Perspective.
Via
Chartmill
Zoetis to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 20, 2024
From
Zoetis Inc.
Via
Business Wire
Which Pet Stock Should Get Your Tail Wagging in 2024?
August 13, 2024
ZTS stock and CHWY stock have different investment cases, but here's what investors may want to consider before buying either of these pet stocks
Via
MarketBeat
Topics
Artificial Intelligence
Animal Health Firm Zoetis Clocks Strong Q2 Earnings, Companion Animal Operations Boost Confidence For 2024
↗
August 06, 2024
Zoetis stock rises as Q2 revenue hits $2.36 billion, up 8% YOY, surpassing estimates. U.S. revenue grew 12%, driven by strong sales of companion animal products like Librela and Solensia. The company...
Via
Benzinga
ZTS Stock Earnings: Zoetis Beats EPS, Beats Revenue for Q2 2024
↗
August 06, 2024
ZTS stock results show that Zoetis beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Zoetis (ZTS) Q2 2024 Earnings Call Transcript
↗
August 06, 2024
ZTS earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Zoetis Announces Second Quarter 2024 Results
August 06, 2024
From
Zoetis Inc.
Via
Business Wire
Home Depot To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Monday
↗
August 05, 2024
Via
Benzinga
Zoetis Announces Authorization of Multi-Year $6 Billion Share Repurchase Program
August 01, 2024
From
Zoetis Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today